DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms

Kevin D. Healy, Louis Hodgson, Tai Young Kim, Adam Shutes, Savitri Maddileti, Rudolph L. Juliano, Klaus M. Hahn, T. Kendall Harden, Yung Jue Bang, Channing J. Der

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Expression of the tumor suppressor deleted in liver cancer-1 (DLC-1) is lost in non-small cell lung (NSCLC) and other human carcinomas, and ectopic DLC-1 expression dramatically reduces proliferation and tumorigenicity. DLC-1 is a multi-domain protein that includes a Rho GTPase activating protein (RhoGAP) domain which has been hypothesized to be the basis of its tumor suppressive actions. To address the importance of the RhoGAP function of DLC-1 in tumor suppression, we performed biochemical and biological studies evaluating DLC-1 in NSCLC. Full-length DLC-1 exhibited strong GAP activity for RhoA as well as RhoB and RhoC, but only very limited activity for Cdc42 in vitro. In contrast, the isolated RhoGAP domain showed 5- to 20-fold enhanced activity for RhoA, RhoB, RhoC, and Cdc42. DLC-1 protein expression was absent in six of nine NSCLC cell lines. Restoration of DLC-1 expression in DLC-1-deficient NSCLC cell lines reduced RhoA activity, and experiments with a RhoA biosensor demonstrated that DLC-1 dramatically reduces RhoA activity at the leading edge of cellular protrusions. Furthermore, DLC-1 expression in NSCLC cell lines impaired both anchorage-dependent and -independent growth, as well as invasion in vitro. Surprisingly, we found that the antitumor activity of DLC-1 was due to both RhoGAP-dependent and -independent activities. Unlike the rat homologue p122RhoGAP, DLC-1 was not capable of activating the phospholipid hydrolysis activity of phospholipase C-δ1. Combined, these studies provide information on the mechanism of DLC-1 function and regulation, and further support the role of DLC-1 tumor suppression in NSCLC.

Original languageEnglish (US)
Pages (from-to)326-337
Number of pages12
JournalMolecular Carcinogenesis
Volume47
Issue number5
DOIs
StatePublished - May 2008
Externally publishedYes

Fingerprint

Liver Neoplasms
Non-Small Cell Lung Carcinoma
Growth
rho GTPase-activating protein
Cell Line
Neoplasms
Cell Surface Extensions
Biosensing Techniques
Type C Phospholipases
Phospholipids
Hydrolysis

Keywords

  • GTPase activating protein
  • Rho GTPases
  • Tumor suppressor

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology

Cite this

DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms. / Healy, Kevin D.; Hodgson, Louis; Kim, Tai Young; Shutes, Adam; Maddileti, Savitri; Juliano, Rudolph L.; Hahn, Klaus M.; Harden, T. Kendall; Bang, Yung Jue; Der, Channing J.

In: Molecular Carcinogenesis, Vol. 47, No. 5, 05.2008, p. 326-337.

Research output: Contribution to journalArticle

Healy, KD, Hodgson, L, Kim, TY, Shutes, A, Maddileti, S, Juliano, RL, Hahn, KM, Harden, TK, Bang, YJ & Der, CJ 2008, 'DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms', Molecular Carcinogenesis, vol. 47, no. 5, pp. 326-337. https://doi.org/10.1002/mc.20389
Healy, Kevin D. ; Hodgson, Louis ; Kim, Tai Young ; Shutes, Adam ; Maddileti, Savitri ; Juliano, Rudolph L. ; Hahn, Klaus M. ; Harden, T. Kendall ; Bang, Yung Jue ; Der, Channing J. / DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms. In: Molecular Carcinogenesis. 2008 ; Vol. 47, No. 5. pp. 326-337.
@article{25c0eeeba40d45978e37061ebfec9ee4,
title = "DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms",
abstract = "Expression of the tumor suppressor deleted in liver cancer-1 (DLC-1) is lost in non-small cell lung (NSCLC) and other human carcinomas, and ectopic DLC-1 expression dramatically reduces proliferation and tumorigenicity. DLC-1 is a multi-domain protein that includes a Rho GTPase activating protein (RhoGAP) domain which has been hypothesized to be the basis of its tumor suppressive actions. To address the importance of the RhoGAP function of DLC-1 in tumor suppression, we performed biochemical and biological studies evaluating DLC-1 in NSCLC. Full-length DLC-1 exhibited strong GAP activity for RhoA as well as RhoB and RhoC, but only very limited activity for Cdc42 in vitro. In contrast, the isolated RhoGAP domain showed 5- to 20-fold enhanced activity for RhoA, RhoB, RhoC, and Cdc42. DLC-1 protein expression was absent in six of nine NSCLC cell lines. Restoration of DLC-1 expression in DLC-1-deficient NSCLC cell lines reduced RhoA activity, and experiments with a RhoA biosensor demonstrated that DLC-1 dramatically reduces RhoA activity at the leading edge of cellular protrusions. Furthermore, DLC-1 expression in NSCLC cell lines impaired both anchorage-dependent and -independent growth, as well as invasion in vitro. Surprisingly, we found that the antitumor activity of DLC-1 was due to both RhoGAP-dependent and -independent activities. Unlike the rat homologue p122RhoGAP, DLC-1 was not capable of activating the phospholipid hydrolysis activity of phospholipase C-δ1. Combined, these studies provide information on the mechanism of DLC-1 function and regulation, and further support the role of DLC-1 tumor suppression in NSCLC.",
keywords = "GTPase activating protein, Rho GTPases, Tumor suppressor",
author = "Healy, {Kevin D.} and Louis Hodgson and Kim, {Tai Young} and Adam Shutes and Savitri Maddileti and Juliano, {Rudolph L.} and Hahn, {Klaus M.} and Harden, {T. Kendall} and Bang, {Yung Jue} and Der, {Channing J.}",
year = "2008",
month = "5",
doi = "10.1002/mc.20389",
language = "English (US)",
volume = "47",
pages = "326--337",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms

AU - Healy, Kevin D.

AU - Hodgson, Louis

AU - Kim, Tai Young

AU - Shutes, Adam

AU - Maddileti, Savitri

AU - Juliano, Rudolph L.

AU - Hahn, Klaus M.

AU - Harden, T. Kendall

AU - Bang, Yung Jue

AU - Der, Channing J.

PY - 2008/5

Y1 - 2008/5

N2 - Expression of the tumor suppressor deleted in liver cancer-1 (DLC-1) is lost in non-small cell lung (NSCLC) and other human carcinomas, and ectopic DLC-1 expression dramatically reduces proliferation and tumorigenicity. DLC-1 is a multi-domain protein that includes a Rho GTPase activating protein (RhoGAP) domain which has been hypothesized to be the basis of its tumor suppressive actions. To address the importance of the RhoGAP function of DLC-1 in tumor suppression, we performed biochemical and biological studies evaluating DLC-1 in NSCLC. Full-length DLC-1 exhibited strong GAP activity for RhoA as well as RhoB and RhoC, but only very limited activity for Cdc42 in vitro. In contrast, the isolated RhoGAP domain showed 5- to 20-fold enhanced activity for RhoA, RhoB, RhoC, and Cdc42. DLC-1 protein expression was absent in six of nine NSCLC cell lines. Restoration of DLC-1 expression in DLC-1-deficient NSCLC cell lines reduced RhoA activity, and experiments with a RhoA biosensor demonstrated that DLC-1 dramatically reduces RhoA activity at the leading edge of cellular protrusions. Furthermore, DLC-1 expression in NSCLC cell lines impaired both anchorage-dependent and -independent growth, as well as invasion in vitro. Surprisingly, we found that the antitumor activity of DLC-1 was due to both RhoGAP-dependent and -independent activities. Unlike the rat homologue p122RhoGAP, DLC-1 was not capable of activating the phospholipid hydrolysis activity of phospholipase C-δ1. Combined, these studies provide information on the mechanism of DLC-1 function and regulation, and further support the role of DLC-1 tumor suppression in NSCLC.

AB - Expression of the tumor suppressor deleted in liver cancer-1 (DLC-1) is lost in non-small cell lung (NSCLC) and other human carcinomas, and ectopic DLC-1 expression dramatically reduces proliferation and tumorigenicity. DLC-1 is a multi-domain protein that includes a Rho GTPase activating protein (RhoGAP) domain which has been hypothesized to be the basis of its tumor suppressive actions. To address the importance of the RhoGAP function of DLC-1 in tumor suppression, we performed biochemical and biological studies evaluating DLC-1 in NSCLC. Full-length DLC-1 exhibited strong GAP activity for RhoA as well as RhoB and RhoC, but only very limited activity for Cdc42 in vitro. In contrast, the isolated RhoGAP domain showed 5- to 20-fold enhanced activity for RhoA, RhoB, RhoC, and Cdc42. DLC-1 protein expression was absent in six of nine NSCLC cell lines. Restoration of DLC-1 expression in DLC-1-deficient NSCLC cell lines reduced RhoA activity, and experiments with a RhoA biosensor demonstrated that DLC-1 dramatically reduces RhoA activity at the leading edge of cellular protrusions. Furthermore, DLC-1 expression in NSCLC cell lines impaired both anchorage-dependent and -independent growth, as well as invasion in vitro. Surprisingly, we found that the antitumor activity of DLC-1 was due to both RhoGAP-dependent and -independent activities. Unlike the rat homologue p122RhoGAP, DLC-1 was not capable of activating the phospholipid hydrolysis activity of phospholipase C-δ1. Combined, these studies provide information on the mechanism of DLC-1 function and regulation, and further support the role of DLC-1 tumor suppression in NSCLC.

KW - GTPase activating protein

KW - Rho GTPases

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=42949100728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949100728&partnerID=8YFLogxK

U2 - 10.1002/mc.20389

DO - 10.1002/mc.20389

M3 - Article

C2 - 17932950

AN - SCOPUS:42949100728

VL - 47

SP - 326

EP - 337

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 5

ER -